These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Brain receptors for dopamine and neuroleptics. Seeman P; Titeler M; Tedesco J; Weinreich P; Sinclair D Adv Biochem Psychopharmacol; 1978; 19():167-76. PubMed ID: 29446 [No Abstract] [Full Text] [Related]
8. Differential distribution of opiate and neuroleptic receptors and dopamine-sensitive adenylate cyclase in rat brain. Leysen J; Laduron P Life Sci; 1977 Jan; 20(2):281-8. PubMed ID: 190508 [No Abstract] [Full Text] [Related]
9. Differential stereoselectivity of methotrimeprazine enantiomers for selected central nervous system receptor types. Robert TA; Hagardorn AN; Daigneault EA Mol Pharmacol; 1982 Mar; 21(2):315-9. PubMed ID: 6285167 [TBL] [Abstract][Full Text] [Related]
10. Binding properties of 3H-lofentanil at the opiate receptor. Gommeren W; Leysen JE Arch Int Pharmacodyn Ther; 1982 Jul; 258(1):171-3. PubMed ID: 6291471 [No Abstract] [Full Text] [Related]
11. Discrimination of three types of opioid binding sites in rat brain in vivo. Rosenbaum JS; Holford NH; Richards ML; Aman RA; Sadée W Mol Pharmacol; 1984 Mar; 25(2):242-8. PubMed ID: 6321946 [TBL] [Abstract][Full Text] [Related]
12. 3H-Apomorphine receptors in various rat brain regions: a study of specific and nonspecific binding and the influence of chronic neuroleptic treatment. Leysen JE Adv Biochem Psychopharmacol; 1980; 24():123-32. PubMed ID: 6105770 [No Abstract] [Full Text] [Related]
13. [Regulation of opioid receptors by thyroliberin analogues]. Balashov AM; Aliab'eva TN; Panchenko LF Vopr Med Khim; 2002; 48(5):436-42. PubMed ID: 12498084 [TBL] [Abstract][Full Text] [Related]
14. Modulatory role of lysophosphatidic acid on opioid receptor binding. Apaydin S; Oktem HA Neurobiology (Bp); 1998; 6(4):421-7. PubMed ID: 10220777 [TBL] [Abstract][Full Text] [Related]
15. Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity. Leysen JE; Janssen PM; Megens AA; Schotte A J Clin Psychiatry; 1994 May; 55 Suppl():5-12. PubMed ID: 7520908 [TBL] [Abstract][Full Text] [Related]
16. Possible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in rats. Hamurtekin E; Bagdas D; Gurun MS Neurosci Lett; 2007 Jun; 420(2):116-21. PubMed ID: 17531379 [TBL] [Abstract][Full Text] [Related]
17. Haloperidol binding to an opiate receptor site. Clay GA; Brougham LR Biochem Pharmacol; 1975 Jul; 24(13-14):1363-7. PubMed ID: 1148026 [No Abstract] [Full Text] [Related]
18. Naloxone-sensitive, haloperidol-sensitive, [3H](+)SKF-10047-binding protein partially purified from rat liver and rat brain membranes: an opioid/sigma receptor? Tsao LI; Su TP Synapse; 1997 Feb; 25(2):117-24. PubMed ID: 9021892 [TBL] [Abstract][Full Text] [Related]
19. Receptor binding properties in vitro and in vivo of some long-acting opiates. Leysen JE; Laduron PM Arch Int Pharmacodyn Ther; 1978 Apr; 232(2):243-6. PubMed ID: 209755 [No Abstract] [Full Text] [Related]
20. [Inactivation of naloxone binding with opioid receptors in rat brain membranes]. Belokoneva OS; Mal'tseva EL; Zaĭtsev SV; Pal'mina NP Biokhimiia; 1993 Dec; 58(12):1945-58. PubMed ID: 8292655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]